ProclaimRx Launches AI Platform for Pharmaceutical Commercial Intelligence

October 20, 2025
ProclaimRx has introduced an enterprise-grade AI platform designed to transform complex pharmaceutical data into real-time, decision-ready intelligence, as announced in a press release. The company also appointed Eugene Lee as Chief Commercial Officer and Kathy Contratto as Vice President of Customer Operations.

ProclaimRx has launched an enterprise-grade AI platform that converts complex pharmaceutical data into real-time, decision-ready insights, announced in a press release. The platform, powered by the PLAiTO Intelligence Engine, aims to replace manual analysis processes with automated intelligence to help commercial teams optimize investments, target customers, and analyze performance within minutes.

The company stated that the platform can automate brand and sales data analysis, reclaiming up to 15 hours per week, and supports investment decisions through on-demand simulations and modeling. It also provides access to proprietary benchmarks and insights while maintaining enterprise-level data security.

As part of the launch, ProclaimRx appointed Eugene Lee as Chief Commercial Officer and Kathy Contratto as Vice President of Customer Operations. Both bring extensive experience in healthcare and life sciences leadership roles. The company will showcase live demos and host an interactive panel at the Pharma CX Marketing Summit in Philadelphia on October 20–21, 2025.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

10/20
C2A Security Acquires Vigilant Ops to Expand AI-Powered Product Security
10/20
Cedar Launches Cedar Cover to Help Hospitals Manage Medicaid and Uninsured Patients
10/20
AbbVie Acquires Gilgamesh Pharmaceuticals' Psychedelic Candidate Bretisilocin
10/20
ESMO Issues First Guidelines for Safe Use of AI Language Models in Oncology
10/20
HDAI Unveils Real-Time AI Chart Summaries at HLTH 2025

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more

You May Also Like